Cetera Advisor Networks’s Galectin Therapeutics GALT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-16,006
| Closed | -$35K | – | 1895 |
|
2021
Q1 | $35K | Hold |
16,006
| – | – | ﹤0.01% | 1468 |
|
2020
Q4 | $36K | Hold |
16,006
| – | – | ﹤0.01% | 1339 |
|
2020
Q3 | $43K | Sell |
16,006
-455
| -3% | -$1.22K | ﹤0.01% | 1228 |
|
2020
Q2 | $50K | Hold |
16,461
| – | – | ﹤0.01% | 1883 |
|
2020
Q1 | $32K | Hold |
16,461
| – | – | ﹤0.01% | 1103 |
|
2019
Q4 | $47K | Hold |
16,461
| – | – | ﹤0.01% | 1228 |
|
2019
Q3 | $60K | Sell |
16,461
-2,560
| -13% | -$9.33K | ﹤0.01% | 1170 |
|
2019
Q2 | $79K | Hold |
19,021
| – | – | ﹤0.01% | 1159 |
|
2019
Q1 | $96K | Hold |
19,021
| – | – | ﹤0.01% | 1113 |
|
2018
Q4 | $66K | Sell |
19,021
-14,700
| -44% | -$51K | ﹤0.01% | 1014 |
|
2018
Q3 | $203K | Hold |
33,721
| – | – | 0.01% | 1045 |
|
2018
Q2 | $215K | Buy |
+33,721
| New | +$215K | 0.01% | 752 |
|
2018
Q1 | – | Sell |
-15,721
| Closed | -$53K | – | 893 |
|
2017
Q4 | $53K | Hold |
15,721
| – | – | ﹤0.01% | 975 |
|
2017
Q3 | $34K | Hold |
15,721
| – | – | ﹤0.01% | 907 |
|
2017
Q2 | $38K | Buy |
+15,721
| New | +$38K | ﹤0.01% | 910 |
|